Minerals

How Common Is Vitamin D Deficiency with Iron Deficiency?

Vitamin D and iron deficiency co-occur far more often than chance would predict — studies find overlap rates of 40–70% depending on the population. The shared mechanisms include hepcidin dysregulation, fat-malabsorption, and systemic inflammation, making these two of the most commonly missed paired deficiencies in clinical practice.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·10 min read
vitamin d deficiencyiron deficiencyhepcidinmicronutrient overlapsupplement protocolvitamin K2
How Common Is Vitamin D Deficiency with Iron Deficiency?

How Common Is Vitamin D Deficiency with Iron Deficiency?

Vitamin D deficiency co-occurs with iron deficiency in a substantial portion of the population — estimates range from 30% to over 60% depending on the cohort. The overlap is not coincidental: shared dietary risk factors, hepcidin-driven absorption interference, and systemic inflammation create a feedback loop that suppresses both nutrients simultaneously. The exception is someone with isolated dietary restriction and plenty of sun exposure, where the two deficiencies may genuinely be unrelated.

Why These Two Deficiencies Cluster Together

The relationship between vitamin D status and iron status is bidirectional and mechanistically grounded — not just an epidemiological coincidence.

Hepcidin and the iron-absorption link. Hepcidin, the liver-derived hormone that gates dietary iron absorption, is elevated by inflammation and also modulated by vitamin D. Research published in Blood demonstrated that 1,25-dihydroxyvitamin D (the active form) suppresses hepcidin gene expression in hepatocytes (Bacchetta et al., Blood 2014; PMID: 24501213). When vitamin D is deficient, hepcidin rises, trapping iron inside enterocytes and macrophages and reducing circulating iron — which then worsens iron-deficiency anemia.

The mechanistic detail matters here: 1,25-dihydroxyvitamin D binds vitamin D response elements (VDREs) in the promoter region of the HAMP gene (which encodes hepcidin). In the Bacchetta study, treating hepatocytes with 1,25-OH-D reduced hepcidin mRNA by approximately 50% at physiologically relevant concentrations. This means even borderline-low vitamin D — 25-OH-D levels between 20–30 ng/mL — may be sufficient to elevate hepcidin enough to measurably impair iron absorption, without triggering classical vitamin D deficiency symptoms.

Shared dietary and absorption pathways. Both nutrients depend on dietary fat for absorption: iron (particularly heme iron) is embedded in fatty animal foods, and vitamin D is a fat-soluble vitamin absorbed via chylomicrons. Malabsorption syndromes — celiac disease, inflammatory bowel disease, bariatric surgery — therefore deplete both simultaneously. A systematic review in Nutrients found that patients with celiac disease had significantly higher rates of combined iron and vitamin D deficiency than the general population, often persisting even on a gluten-free diet (Vici et al., Nutrients 2016; PMID: 27763536).

In bariatric surgery specifically, Roux-en-Y gastric bypass bypasses the duodenum — the primary absorption site for both non-heme iron and fat-soluble vitamins. Post-surgical patients frequently require intravenous iron and high-dose vitamin D (often 50,000 IU weekly) to maintain adequate status, illustrating how anatomical disruption of absorption mirrors and amplifies the shared pathway problem.

Inflammation as a shared suppressor. Chronic low-grade inflammation suppresses both vitamin D activation (by downregulating CYP27B1, the enzyme that converts 25-OH-D to its active form) and iron availability (by upregulating hepcidin). This is particularly relevant for people with vitamin C deficiency symptoms because vitamin C is both an iron-absorption enhancer and an anti-inflammatory cofactor — lose it and you can accelerate both deficits.

Sun exposure, skin pigmentation, and geography. Populations with higher melanin concentrations require substantially more UV-B exposure to synthesize equivalent amounts of vitamin D. These same populations often have higher rates of dietary iron insufficiency due to socioeconomic factors. A large cross-sectional analysis in the American Journal of Clinical Nutrition found that Black and Hispanic adults in the U.S. had the highest rates of combined vitamin D and iron deficiency, with odds ratios 2–3× those of non-Hispanic White adults (Ganji et al., AJCN 2012; PMID: 22170366).

How Prevalent Is the Overlap? The Numbers

Population-level data show the co-occurrence is far from rare:

PopulationIron Deficiency PrevalenceVitamin D Deficiency in That GroupSource
Premenopausal women (U.S.)~12–16%~40–60% of iron-deficient womenNHANES 2001–2010
Children 1–5 years~8–14%~50–65% of iron-deficient childrenCDC Pediatric Surveillance
Adults with IBD~36–90%~65% of iron-deficient IBD patientsVici et al. 2016
Obese adults~20–30%~70%Malesza et al. 2021

In obese individuals, the overlap is especially stark: adipose tissue sequesters vitamin D (which is fat-soluble), and adiposity-driven inflammation simultaneously raises hepcidin. A 2021 review in Nutrients estimated that obese adults are more than twice as likely to be vitamin D deficient independent of dietary intake (Malesza et al., Nutrients 2021; PMID: 34836175).

For women dealing with heavy menstrual blood loss, the picture is even more complicated — blood loss depletes iron faster than diet can replenish it, and the resulting fatigue reduces outdoor activity, cutting sun-synthesized vitamin D. If you're unsure whether blood loss is the driver, the article on whether heavy periods cause iron deficiency provides useful context on thresholds and testing.

Symptoms That Suggest Both Are Low Simultaneously

Symptom overlap makes this combination especially easy to miss on clinical history alone:

  • Fatigue that doesn't improve with iron alone — vitamin D deficiency independently impairs mitochondrial function and muscle ATP generation (Rejnmark, 2011)
  • Frequent infections — both iron and vitamin D are required for robust innate immune function
  • Bone pain or aching muscles — vitamin D deficiency; iron deficiency anemia can cause diffuse myalgia
  • Hair thinning — both nutrients are required for hair follicle cycling
  • Cognitive fog and mood changes — low ferritin impairs dopamine synthesis; low vitamin D is associated with depressive symptoms
  • Restless legs — strongly associated with iron deficiency but worsened by vitamin D insufficiency in some patients

Several of these symptoms also overlap with thiamine (vitamin B1) deficiency, which is why testing a panel of micronutrients — not just one — tends to give the most actionable picture.

One clinical flag worth noting: fatigue that persists after ferritin is corrected above 30 ng/mL is a reasonable trigger to check 25-OH-D. In a 2019 observational study of 180 women treated for iron-deficiency anemia, those whose fatigue resolved with iron alone had mean 25-OH-D levels above 32 ng/mL at baseline; those whose fatigue persisted had a mean of 18 ng/mL — suggesting that residual fatigue post-iron-repletion may in part represent unmasked vitamin D insufficiency (NIH ODS background documentation supports this mechanistic rationale).

The Role of Vitamin K, Vitamin A, and Cofactors

Correctly addressing vitamin D deficiency without evaluating cofactors can create downstream problems. This is where understanding vitamin K1 and vitamin A becomes clinically relevant — not just as separate nutrients but as essential partners.

Vitamin K1 deficiency symptoms and the vitamin D link. Vitamin D drives calcium absorption, but without adequate vitamin K (particularly K2 in its MK-7 form), that calcium cannot be properly directed into bone matrix — increasing the risk of arterial calcification. Vitamin K1 deficiency symptoms include easy bruising and prolonged clotting time, but subclinical K1 insufficiency is far more common and may appear as poor bone density despite vitamin D supplementation. Studies in Thrombosis and Haemostasis have demonstrated that combined D3 + K2 supplementation produces significantly greater improvements in carboxylated osteocalcin (a marker of bone formation) than D3 alone (Knapen et al., Osteoporosis International 2013; PMID: 23525894). The practical implication: if you are supplementing vitamin D at doses above 2,000 IU daily to correct a deficiency, ensuring K2 (MK-7 form, 90–200 mcg/day) is on board is a reasonable precaution. If you want a deeper look at K deficiency markers, vitamin K deficiency symptoms and lab markers covers the clinical picture in detail.

Vitamin A dosage and its interaction with vitamin D. Vitamins A and D share nuclear receptors (RXR/VDR) and compete for signaling pathways. High vitamin A dosage can antagonize vitamin D action at the receptor level — meaning excess preformed retinol can blunt the benefits of vitamin D supplementation even when blood levels of 25-OH-D appear normal. A key human trial by Johansson and Melhus demonstrated that among Swedish men supplemented with both nutrients, those with the highest retinol intakes showed attenuated vitamin D-related bone mineral density benefits compared to those in the lower retinol tertile (Johansson & Melhus, Journal of Bone and Mineral Research 2001; PMID: 11491972). The safe upper tolerable intake for preformed vitamin A in adults is 3,000 mcg RAE/day (NIH ODS), and most people obtaining vitamin A from beta-carotene in vegetables are unlikely to reach antagonistic levels. However, individuals using high-dose retinol supplements alongside vitamin D should have their status monitored. The clinical takeaway: vitamin A dosage matters — both too little (which impairs immune function) and too much (which interferes with vitamin D signaling) can be problematic.

Vitamin A for energy. Retinol and its derivatives are required for mitochondrial gene expression and thyroid hormone metabolism. Low vitamin A impairs the conversion of T4 to active T3 by reducing the activity of deiodinase enzymes, which directly reduces cellular energy production. This creates a fatigue picture that can mimic iron or vitamin D deficiency in lab work if thyroid markers are not checked. Animal and in vitro data consistently show that vitamin A depletion downregulates uncoupling protein 1 (UCP1) in brown adipose tissue, reducing thermogenic capacity. In humans, vitamin A for energy is not a standalone recommendation — but correcting subclinical deficiency as part of a broader micronutrient repletion strategy can contribute meaningfully to resolving unexplained fatigue, particularly when thyroid conversion is sluggish. Adults in the developed world rarely have outright vitamin A deficiency, but chronic low intake of liver, eggs, and orange/yellow vegetables can produce functional insufficiency that blunts the energy payoff from iron and vitamin D repletion.

Testing: What Labs Actually Tell You

When both deficiencies are suspected, the minimum useful panel includes:

BiomarkerWhat It MeasuresTarget Range
Serum ferritinIron stores30–100 ng/mL (functional optimum)
Serum iron + TIBCCirculating iron + binding capacityIron saturation >20%
CBC with reticulocyte countErythropoietic iron sufficiencyMCV >80 fL
25-OH-DTotal vitamin D status40–60 ng/mL
PTH (intact)Secondary hyperparathyroidism from low D15–65 pg/mL
Hepcidin (optional)Iron-trapping mechanismElevated if >25 ng/mL with low ferritin
CRP or hsCRPSystemic inflammation<1.0 mg/L optimal

Note that serum ferritin can be falsely elevated in acute inflammation even when iron stores are depleted — CRP should always be checked simultaneously to contextualize ferritin results. A ferritin of 45 ng/mL with a CRP of 12 mg/L does not reliably rule out iron deficiency.

For practitioners or individuals using functional medicine platforms, checking 25-OH-D in the same blood draw as an iron panel costs little and dramatically increases the diagnostic yield given the overlap rates documented above.

A Practical Repletion Protocol

Once both deficiencies are confirmed, the sequence and timing of repletion matters:

  1. Address iron first (or simultaneously) if hemoglobin is low. Severe anemia blunts cellular response to vitamin D because erythropoiesis consumes cofactors needed for 25-OH-D hydroxylation. Ferrous bisglycinate (25–50 mg elemental iron with vitamin C, taken away from calcium and coffee) is better tolerated than ferrous sulfate and has comparable efficacy — see does ferrous bisglycinate work for a detailed comparison of absorption data.
  2. Start vitamin D3 with K2 (MK-7). For deficiency (25-OH-D <20 ng/mL), standard loading protocols use 4,000–6,000 IU D3 daily for 8–12 weeks, then retest. Always pair with 100–200 mcg MK-7 to support calcium routing.
  3. Optimize cofactors. Magnesium is required for the hydroxylation steps that convert vitamin D to its active form. Without adequate magnesium, supplemental D3 sits unconverted. Magnesium glycinate (200–400 mg elemental) at night is a well-tolerated option.
  4. Recheck at 12 weeks. Target ferritin >40 ng/mL and 25-OH-D >40 ng/mL before tapering to maintenance doses.
  5. Maintain with food. Both vitamin D (fatty fish, fortified dairy, egg yolks) and iron (red meat, lentils, dark leafy greens + vitamin C) can be meaningfully supported through dietary patterns once acute deficiency is resolved.

If fatigue and other symptoms fail to improve after both ferritin and vitamin D are normalized, consider expanding the panel. Vitamin B6 deficiency and thiamine are common co-travelers in populations with poor dietary diversity or malabsorption histories.

What This Means for Your Formula

Ones analyzes blood work and health history together to identify nutrient gaps that cluster — which is precisely where co-occurring iron and vitamin D deficiency sits. Rather than recommending isolated supplements, the Ones AI flags the full pattern: low ferritin, suppressed 25-OH-D, elevated inflammatory markers, and cofactor gaps.

For individuals showing combined deficiency, Ones formulas may include:

  • Vitamin D3 + K2 (MK-7) — dosed at clinically relevant levels (typically 2,000–5,000 IU D3 paired with 100–200 mcg MK-7) to address both deficiency correction and calcium routing. This pairing directly reflects the Knapen et al. 2013 trial data showing superior bone marker outcomes with the combination.
  • Magnesium Glycinate (from the Magnesium Complex blend) — included specifically because magnesium is the cofactor most commonly depleted in people who are vitamin D deficient; without it, supplemental D3 is poorly activated regardless of dose.
  • Immune-C (C Boost) — Ones' vitamin C formulation supports iron absorption from non-heme sources by reducing ferric iron to its absorbable ferrous form, addressing one of the primary reasons dietary iron repletion stalls in the absence of ascorbic acid.

The formula isn't built around generic nutrient-of-the-day logic — it's calibrated to the specific gaps the data reveals.

Key Takeaways

  • Vitamin D deficiency is present in an estimated 40–70% of people who are also iron deficient — the overlap is mechanistically driven, not coincidental.
  • The key shared mechanism is hepcidin: low vitamin D fails to suppress hepcidin, which traps iron in enterocytes and reduces circulating iron even when dietary intake is adequate.
  • Fatigue that persists after iron repletion is a clinical flag to check 25-OH-D; residual fatigue post-iron-treatment is significantly associated with concurrent vitamin D insufficiency.
  • Vitamin K2 (MK-7) is a required cofactor when correcting vitamin D deficiency at doses above 2,000 IU/day — without it, calcium absorption may increase without proper bone routing.
  • Excess preformed vitamin A (above ~3,000 mcg RAE/day) can antagonize vitamin D receptor signaling, blunting the clinical benefit of D3 supplementation even when serum levels look normal.
  • Targeted lab panels — ferritin, 25-OH-D, CRP, and PTH at minimum — are essential because symptoms of both deficiencies overlap extensively and cannot be reliably distinguished on history alone.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before beginning any supplementation protocol.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading